ALERE INC. 4 SEC Filings | Understand Stock

Filed On	Filing
03 Oct 2017	Form 4: Wygant Jonathan, VP, Controller, CAO Returned 1,909 shares to the issuer · Disposed of 6,666 Restricted Stock Units (Disposition to Issuer)
03 Oct 2017	Form 4: Uppaluri Renuka, Senior VP, Global R&D Returned 13,267 shares to the issuer · Disposed of 75,000 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 22,991 Restricted Stock Units (Disposition to Issuer)
03 Oct 2017	Form 4: Roosevelt James Jr., Director Returned 9,974 shares to the issuer · Disposed of 98,841 Employee Stock Option (Right to Buy) (Disposition to Issuer)
03 Oct 2017	Form 4: Quelch John, Director Returned 26,651 shares to the issuer · Disposed of 97,610 Employee Stock Option (Right to Buy) (Disposition to Issuer)
03 Oct 2017	Form 4: Powers Gregg J, Director Returned 51,530 shares to the issuer · Disposed of 39,820 Employee Stock Option (Right to Buy) (Disposition to Issuer)
03 Oct 2017	Form 4: Pelossof Avi, GlobalPres, Infectious Disease Returned 26,005 shares to the issuer · Disposed of 196,956 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 19,470 Restricted Stock Units (Disposition to Issuer)
03 Oct 2017	Form 4: Nawana Namal, Director Returned 174,129 shares to the issuer · Disposed of 623,077 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 111,041 Restricted Stock Units (Disposition to Issuer) · 1 more
03 Oct 2017	Form 4: McKillop Thomas, Director Returned 5,530 shares to the issuer · Disposed of 53,756 Employee Stock Option (Right to Buy) (Disposition to Issuer)
03 Oct 2017	Form 4: Markison Brian A, Director Returned 5,530 shares to the issuer · Disposed of 53,756 Employee Stock Option (Right to Buy) (Disposition to Issuer)
03 Oct 2017	Form 4: Malkani Sanjay, Global Pres., Toxicology Returned 29,322 shares to the issuer · Disposed of 174,448 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 19,470 Restricted Stock Units (Disposition to Issuer)
03 Oct 2017	Form 4: Levy John F, Director Returned 172,223 shares to the issuer · Disposed of 105,430 Employee Stock Option (Right to Buy) (Disposition to Issuer)
03 Oct 2017	Form 4: Hinrichs James F., Executive VP, CFO Returned 72,230 shares to the issuer · Disposed of 358,118 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 44,350 Restricted Stock Units (Disposition to Issuer)
03 Oct 2017	Form 4: Hargadon Robert Bernard, SVP, Global Human Resources Returned 26,190 shares to the issuer · Disposed of 71,650 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 16,324 Restricted Stock Units (Disposition to Issuer)
03 Oct 2017	Form 4: Guerdan Melissa, SVP, Global Quality & Reg. Returned 16,385 shares to the issuer · Disposed of 52,461 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 19,470 Restricted Stock Units (Disposition to Issuer)
03 Oct 2017	Form 4: Goldberg Carol R, Director Returned 85,211 shares to the issuer · Disposed of 75,200 Employee Stock Option (Right to Buy) (Disposition to Issuer)
03 Oct 2017	Form 4: Gladwell Mark, Senior VP, Global Operations Returned 9,791 shares to the issuer · Disposed of 56,778 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 16,324 Restricted Stock Units (Disposition to Issuer)
03 Oct 2017	Form 4: Ginsburg Geoffrey S, Director Returned 5,530 shares to the issuer
03 Oct 2017	Form 4: Cramp Daniella, Global Pres., Cardiometabolic Returned 28,573 shares to the issuer · Disposed of 228,709 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 19,470 Restricted Stock Units (Disposition to Issuer)
03 Oct 2017	Form 4: Chiniara Ellen, GC, Chief Ethics Officer&Sec Returned 32,764 shares to the issuer · Disposed of 77,844 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 19,470 Restricted Stock Units (Disposition to Issuer)
03 Oct 2017	Form 4: Bridgen John, Sr VP, Business Development Returned 20,646 shares to the issuer · Disposed of 50,038 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 16,324 Restricted Stock Units (Disposition to Issuer)

03 Oct 2017

Form 4: Wygant Jonathan, VP, Controller, CAO

Returned 1,909 shares to the issuer · Disposed of 6,666 Restricted Stock Units (Disposition to Issuer)

03 Oct 2017

Form 4: Uppaluri Renuka, Senior VP, Global R&D

Returned 13,267 shares to the issuer · Disposed of 75,000 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 22,991 Restricted Stock Units (Disposition to Issuer)

03 Oct 2017

Form 4: Roosevelt James Jr., Director

Returned 9,974 shares to the issuer · Disposed of 98,841 Employee Stock Option (Right to Buy) (Disposition to Issuer)

03 Oct 2017

Form 4: Quelch John, Director

Returned 26,651 shares to the issuer · Disposed of 97,610 Employee Stock Option (Right to Buy) (Disposition to Issuer)

03 Oct 2017

Form 4: Powers Gregg J, Director

Returned 51,530 shares to the issuer · Disposed of 39,820 Employee Stock Option (Right to Buy) (Disposition to Issuer)

03 Oct 2017

Form 4: Pelossof Avi, GlobalPres, Infectious Disease

Returned 26,005 shares to the issuer · Disposed of 196,956 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 19,470 Restricted Stock Units (Disposition to Issuer)

03 Oct 2017

Form 4: Nawana Namal, Director

Returned 174,129 shares to the issuer · Disposed of 623,077 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 111,041 Restricted Stock Units (Disposition to Issuer) · 1 more

03 Oct 2017

Form 4: McKillop Thomas, Director

Returned 5,530 shares to the issuer · Disposed of 53,756 Employee Stock Option (Right to Buy) (Disposition to Issuer)

03 Oct 2017

Form 4: Markison Brian A, Director

Returned 5,530 shares to the issuer · Disposed of 53,756 Employee Stock Option (Right to Buy) (Disposition to Issuer)

03 Oct 2017

Form 4: Malkani Sanjay, Global Pres., Toxicology

Returned 29,322 shares to the issuer · Disposed of 174,448 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 19,470 Restricted Stock Units (Disposition to Issuer)

03 Oct 2017

Form 4: Levy John F, Director

Returned 172,223 shares to the issuer · Disposed of 105,430 Employee Stock Option (Right to Buy) (Disposition to Issuer)

03 Oct 2017

Form 4: Hinrichs James F., Executive VP, CFO

Returned 72,230 shares to the issuer · Disposed of 358,118 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 44,350 Restricted Stock Units (Disposition to Issuer)

03 Oct 2017

Form 4: Hargadon Robert Bernard, SVP, Global Human Resources

Returned 26,190 shares to the issuer · Disposed of 71,650 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 16,324 Restricted Stock Units (Disposition to Issuer)

03 Oct 2017

Form 4: Guerdan Melissa, SVP, Global Quality & Reg.

Returned 16,385 shares to the issuer · Disposed of 52,461 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 19,470 Restricted Stock Units (Disposition to Issuer)

03 Oct 2017

Form 4: Goldberg Carol R, Director

Returned 85,211 shares to the issuer · Disposed of 75,200 Employee Stock Option (Right to Buy) (Disposition to Issuer)

03 Oct 2017

Form 4: Gladwell Mark, Senior VP, Global Operations

Returned 9,791 shares to the issuer · Disposed of 56,778 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 16,324 Restricted Stock Units (Disposition to Issuer)

03 Oct 2017

Form 4: Ginsburg Geoffrey S, Director

Returned 5,530 shares to the issuer

03 Oct 2017

Form 4: Cramp Daniella, Global Pres., Cardiometabolic

Returned 28,573 shares to the issuer · Disposed of 228,709 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 19,470 Restricted Stock Units (Disposition to Issuer)

03 Oct 2017

Form 4: Chiniara Ellen, GC, Chief Ethics Officer&Sec

Returned 32,764 shares to the issuer · Disposed of 77,844 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 19,470 Restricted Stock Units (Disposition to Issuer)

03 Oct 2017

Form 4: Bridgen John, Sr VP, Business Development

Returned 20,646 shares to the issuer · Disposed of 50,038 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 16,324 Restricted Stock Units (Disposition to Issuer)